Merck KGaA, Darmstadt, Germany, Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO 2018 Congress

DARMSTADT, Germany, Oct. 22, 2018 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, the vibrant science and technology company which operates its healthcare business in the U.S. and Canada as EMD Serono,......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Monday, 22 October

Share |